Drug-induced depression. Incidence, avoidance and management
- PMID: 7913812
- DOI: 10.2165/00002018-199410030-00003
Drug-induced depression. Incidence, avoidance and management
Abstract
According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R), drug-induced depression may be classified as an Organic Mood Syndrome, Depressed Type. Unfortunately, the DSM-III-R diagnostic criteria are not sufficiently precise for application in research, and studies of drug-induced depression have rarely utilised these criteria. Research concerned with drug-induced depression is characterised by a number of methodological complications. These include differing definitions of depression, including depression defined as a symptom, a syndrome, or by diagnostic criteria for a specific mental disorder. In addition, patients undergoing pharmacological treatments for medical illnesses are typically exposed to considerable psychosocial stress due to the suffering and disability associated with illness. These psychosocial factors may in themselves precipitate episodes of depression. Due to these complicating factors, sophisticated study designs are required to confirm an aetiological role for medications as risk factors for depression. Unfortunately, adequate studies have rarely been conducted, and much of the literature consists of case reports and clinical observations. Consequently, clinicians are frequently required to make clinical judgements about the aetiology of patients' depressive symptoms in the absence of definitive scientific information about the role of drugs. Nevertheless, a knowledge of the relevant literature will assist clinicians in making reasoned judgements about the aetiology, prevention and management of these disorders.
Similar articles
-
Can drug-induced depressions be identified by their clinical features?Can J Psychiatry. 1992 Apr;37(3):213-5. Can J Psychiatry. 1992. PMID: 1350503 Review.
-
[Drug-induced depression].Clin Ter. 1980 May 15;93(3):351-5. Clin Ter. 1980. PMID: 6108820 Italian. No abstract available.
-
[Alpha-interferon and mental disorders].Encephale. 2001 Jul-Aug;27(4):308-17. Encephale. 2001. PMID: 11686052 Review. French.
-
[Mixed depression and DSM-5: A critical review].Encephale. 2016 Feb;42(1):90-8. doi: 10.1016/j.encep.2015.08.006. Epub 2015 Oct 21. Encephale. 2016. PMID: 26471516 Review. French.
-
[The difference between depression and melancholia: two distinct conditions that were combined into a single category in DSM-III].Seishin Shinkeigaku Zasshi. 2012;114(8):886-905. Seishin Shinkeigaku Zasshi. 2012. PMID: 23012851 Review. Japanese.
Cited by
-
Behavioural toxicity of medicinal drugs. Practical consequences, incidence, management and avoidance.Drug Saf. 1998 Mar;18(3):189-208. doi: 10.2165/00002018-199818030-00004. Drug Saf. 1998. PMID: 9530538 Review.
-
beta-blockers. Drug interactions of clinical significance.Drug Saf. 1995 Dec;13(6):359-70. doi: 10.2165/00002018-199513060-00005. Drug Saf. 1995. PMID: 8652080 Review.
-
Pregabalin and Methadone Plasma Levels in Patients Receiving Methadone Maintenance Treatment: An Observational Study.Clin Drug Investig. 2025 Aug;45(8):575-582. doi: 10.1007/s40261-025-01460-9. Epub 2025 Jun 28. Clin Drug Investig. 2025. PMID: 40581710
-
The neurobiology of retinoic acid in affective disorders.Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):315-31. doi: 10.1016/j.pnpbp.2007.07.001. Epub 2007 Jul 10. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 17707566 Free PMC article. Review.
-
Using the affective bias test to predict drug-induced negative affect: implications for drug safety.Br J Pharmacol. 2017 Oct;174(19):3200-3210. doi: 10.1111/bph.13972. Epub 2017 Aug 30. Br J Pharmacol. 2017. PMID: 28782244 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources